Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: In search of biomarkers

Sascha Alvermann, Christian Hennig, Olaf Stüve, Heinz Wiendl, Martin Stangel

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

IMPORTANCE: Cerebrospinal fluid (CSF) is the compartment in closest proximity to the central nervous system (CNS) parenchyma and might reflect immune pathology in inflammatory CNS disorders like multiple sclerosis (MS). Multiparameter flow cytometry is used to characterize immunological alterations in the CSF of patients with MS. OBJECTIVES: To present a comprehensive review of the cellular alterations in CSF that distinguish MS from physiological conditions and other CNS disorders; integrate relevant findings into a model of leukocyte trafficking in the CNS; highlight treatment-related changes in leukocyte subsets; and evaluate the potential of CSF immunophenotyping in the search of novel biomarkers in MS. EVIDENCE REVIEW: We searched MEDLINE articles published between 1980 and 2013 that include the flow cytometric characterization of leukocyte subsets in the CSF of patients with MS. FINDINGS: All of the articles have shown CSF pleocytosis in MS. Interesting results include CSF enrichment of helper T cells (subtypes TH1 and T H17) and regulatory T cells, aswell as intrathecal B-cell differentiation resulting in the generation of antibody-producing plasmablasts and plasma cells. Other leukocyte populations, including natural killer cells, monocytes, and dendritic cells, show alterations as well. Characterization of CSF cells increases our understanding of MS pathogenesis and may provide useful biomarkers for individual prognosis and treatment decisions. However, validation in controlled settings is lacking in most cases. CONCLUSIONS AND RELEVANCE: With the advent of more sophisticated approaches, immunophenotyping of CSF cells in MS might become increasingly important to correlate cellular subsets with different stages of disease activity and remission. An assessment of CSF cell numbers and composition should be incorporated into clinical trials.

Original languageEnglish (US)
Pages (from-to)905-912
Number of pages8
JournalJAMA Neurology
Volume71
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Immunophenotyping
Multiple Sclerosis
Cerebrospinal Fluid
Biomarkers
Leukocytes
Central Nervous System Diseases
Central Nervous System
Cells
Antibody-Producing Cells
Leukocytosis
Regulatory T-Lymphocytes
Helper-Inducer T-Lymphocytes
Plasma Cells
MEDLINE
Natural Killer Cells
Dendritic Cells
Monocytes
Cell Differentiation
Flow Cytometry
B-Lymphocytes

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis : In search of biomarkers. / Alvermann, Sascha; Hennig, Christian; Stüve, Olaf; Wiendl, Heinz; Stangel, Martin.

In: JAMA Neurology, Vol. 71, No. 7, 2014, p. 905-912.

Research output: Contribution to journalArticle

Alvermann, Sascha ; Hennig, Christian ; Stüve, Olaf ; Wiendl, Heinz ; Stangel, Martin. / Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis : In search of biomarkers. In: JAMA Neurology. 2014 ; Vol. 71, No. 7. pp. 905-912.
@article{004aa4b59b5045baac5b6892f09b7e86,
title = "Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: In search of biomarkers",
abstract = "IMPORTANCE: Cerebrospinal fluid (CSF) is the compartment in closest proximity to the central nervous system (CNS) parenchyma and might reflect immune pathology in inflammatory CNS disorders like multiple sclerosis (MS). Multiparameter flow cytometry is used to characterize immunological alterations in the CSF of patients with MS. OBJECTIVES: To present a comprehensive review of the cellular alterations in CSF that distinguish MS from physiological conditions and other CNS disorders; integrate relevant findings into a model of leukocyte trafficking in the CNS; highlight treatment-related changes in leukocyte subsets; and evaluate the potential of CSF immunophenotyping in the search of novel biomarkers in MS. EVIDENCE REVIEW: We searched MEDLINE articles published between 1980 and 2013 that include the flow cytometric characterization of leukocyte subsets in the CSF of patients with MS. FINDINGS: All of the articles have shown CSF pleocytosis in MS. Interesting results include CSF enrichment of helper T cells (subtypes TH1 and T H17) and regulatory T cells, aswell as intrathecal B-cell differentiation resulting in the generation of antibody-producing plasmablasts and plasma cells. Other leukocyte populations, including natural killer cells, monocytes, and dendritic cells, show alterations as well. Characterization of CSF cells increases our understanding of MS pathogenesis and may provide useful biomarkers for individual prognosis and treatment decisions. However, validation in controlled settings is lacking in most cases. CONCLUSIONS AND RELEVANCE: With the advent of more sophisticated approaches, immunophenotyping of CSF cells in MS might become increasingly important to correlate cellular subsets with different stages of disease activity and remission. An assessment of CSF cell numbers and composition should be incorporated into clinical trials.",
author = "Sascha Alvermann and Christian Hennig and Olaf St{\"u}ve and Heinz Wiendl and Martin Stangel",
year = "2014",
doi = "10.1001/jamaneurol.2014.395",
language = "English (US)",
volume = "71",
pages = "905--912",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis

T2 - In search of biomarkers

AU - Alvermann, Sascha

AU - Hennig, Christian

AU - Stüve, Olaf

AU - Wiendl, Heinz

AU - Stangel, Martin

PY - 2014

Y1 - 2014

N2 - IMPORTANCE: Cerebrospinal fluid (CSF) is the compartment in closest proximity to the central nervous system (CNS) parenchyma and might reflect immune pathology in inflammatory CNS disorders like multiple sclerosis (MS). Multiparameter flow cytometry is used to characterize immunological alterations in the CSF of patients with MS. OBJECTIVES: To present a comprehensive review of the cellular alterations in CSF that distinguish MS from physiological conditions and other CNS disorders; integrate relevant findings into a model of leukocyte trafficking in the CNS; highlight treatment-related changes in leukocyte subsets; and evaluate the potential of CSF immunophenotyping in the search of novel biomarkers in MS. EVIDENCE REVIEW: We searched MEDLINE articles published between 1980 and 2013 that include the flow cytometric characterization of leukocyte subsets in the CSF of patients with MS. FINDINGS: All of the articles have shown CSF pleocytosis in MS. Interesting results include CSF enrichment of helper T cells (subtypes TH1 and T H17) and regulatory T cells, aswell as intrathecal B-cell differentiation resulting in the generation of antibody-producing plasmablasts and plasma cells. Other leukocyte populations, including natural killer cells, monocytes, and dendritic cells, show alterations as well. Characterization of CSF cells increases our understanding of MS pathogenesis and may provide useful biomarkers for individual prognosis and treatment decisions. However, validation in controlled settings is lacking in most cases. CONCLUSIONS AND RELEVANCE: With the advent of more sophisticated approaches, immunophenotyping of CSF cells in MS might become increasingly important to correlate cellular subsets with different stages of disease activity and remission. An assessment of CSF cell numbers and composition should be incorporated into clinical trials.

AB - IMPORTANCE: Cerebrospinal fluid (CSF) is the compartment in closest proximity to the central nervous system (CNS) parenchyma and might reflect immune pathology in inflammatory CNS disorders like multiple sclerosis (MS). Multiparameter flow cytometry is used to characterize immunological alterations in the CSF of patients with MS. OBJECTIVES: To present a comprehensive review of the cellular alterations in CSF that distinguish MS from physiological conditions and other CNS disorders; integrate relevant findings into a model of leukocyte trafficking in the CNS; highlight treatment-related changes in leukocyte subsets; and evaluate the potential of CSF immunophenotyping in the search of novel biomarkers in MS. EVIDENCE REVIEW: We searched MEDLINE articles published between 1980 and 2013 that include the flow cytometric characterization of leukocyte subsets in the CSF of patients with MS. FINDINGS: All of the articles have shown CSF pleocytosis in MS. Interesting results include CSF enrichment of helper T cells (subtypes TH1 and T H17) and regulatory T cells, aswell as intrathecal B-cell differentiation resulting in the generation of antibody-producing plasmablasts and plasma cells. Other leukocyte populations, including natural killer cells, monocytes, and dendritic cells, show alterations as well. Characterization of CSF cells increases our understanding of MS pathogenesis and may provide useful biomarkers for individual prognosis and treatment decisions. However, validation in controlled settings is lacking in most cases. CONCLUSIONS AND RELEVANCE: With the advent of more sophisticated approaches, immunophenotyping of CSF cells in MS might become increasingly important to correlate cellular subsets with different stages of disease activity and remission. An assessment of CSF cell numbers and composition should be incorporated into clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84905442636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905442636&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2014.395

DO - 10.1001/jamaneurol.2014.395

M3 - Article

C2 - 24818670

AN - SCOPUS:84905442636

VL - 71

SP - 905

EP - 912

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 7

ER -